We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand

By LabMedica International staff writers
Posted on 27 Jul 2022
Print article
Image: Medlab Asia and Asia Health will take place live and in-person in Thailand (Photo courtesy of Informa Markets)
Image: Medlab Asia and Asia Health will take place live and in-person in Thailand (Photo courtesy of Informa Markets)

Informa Markets (London, UK), in partnership with Impact Muang Thong Thani (Nonthaburi, Thailand), have confirmed that Medlab Asia and Asia Health will take place in Thailand for the first time when the co-located events return live and in-person at the Impact Exhibition Center, Bangkok, from 19-21 October 2022. The exhibitions, the leading events in the ASEAN region for the healthcare and laboratory industry, will showcase the latest techniques and innovations while also welcoming visitors and suppliers from around the world to meet, discuss and do business in the burgeoning healthcare hub of Thailand.

According to government data, sales of clinical laboratory services in Thailand are expected to increase to USD 8.3 billion in 2026, from USD 4.5 billion in 2016. The healthcare sector in the country has also seen a surge in the number of international patients it welcomes, with current figures standing at two million. However, this figure is expected to increase. The co-located events are expected to welcome more than 4,200 attendees during the 10th edition of both events, with more than 300 exhibitors from over 20 countries showcasing the latest innovation in product development and new technologies and insights supporting the healthcare and laboratory industries. Both events are once again expected to be supported by a host of government entities, industry leaders and influencers in their respective sectors.

Forming a vital attribute of both events are the CME, CMTE, CNEU & CPD accredited conferences, each designed to provide peer-to-peer networking while fostering knowledge through insights and expert analysis. Medlab Asia will host six conference tracks, including Laboratory Management, Clinical Chemistry, Clinical Microbiology, Molecular Diagnostics & Therapeutics, Hematology and COVID-19 Updates. The congress focus for Asia Health will look, in detail, at Hospital Procurement, Sterilization, Decontamination & Patient Safety, Doing Healthcare Business in Thailand and Total Radiology. This will be supported by workshops featuring latest technologies in the ASEAN healthcare sector.

A host of exhibitors have already committed to attending the three-day showcase. They include, amongst others, Randox laboratories Ltd, Singapore-based GenScript Biotech, College of American Pathologists, Trivitron Healthcare, Sysmex Asia Pacific, BGI Genomics Co, and Sansure Biotech. As part of Informa's commitment to providing the highest hygiene and safety levels, the event will again take place under the protocols introduced via the company’s Informa AllSecure health and safety mandate. The enhanced measures include 35 guidelines covering all aspects of cleaning and hygiene, social distancing measures, screening, and a track and trace in conjunction with local authorities.

“We are delighted to be relaunching Medlab Asia and Asia Health as a co-located event in Thailand. Both events have been integral to developing the healthcare and laboratory sectors in the ASEAN region over the last decade,” said Tom Coleman, Exhibition Director for Informa Markets. “This is something we are committed to continuing, to ensure the latest technology and insights are given a platform in the region and that both events continue to play a pivotal role in connecting those within the healthcare and laboratory industries.”

“The healthcare industry has faced unprecedented challenges in recent years; however, the industry should be applauded for its efforts in supporting the recovery of businesses globally while also ensuring economic recovery,” added Loy Joon How, General Manager, Impact Muang Thong Thani.

Related Links:
Informa Markets 
Impact Muang Thong Thani
Medlab Asia 
Asia Health 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Nuclear Matrix Protein 22 Test
NMP22 Test
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.